Filter by country
Africa
Sao Tome and Principe
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Lesotho
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Cote d'Ivoire
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Angola
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by Category
Documents
Gavi Process Guidelines
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
Russian
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
VIS
White papers
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
Annual Reports
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
Audit
Spanish
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Audio Visual
Infographics
Presentations
Videos
Galleries
Board
Committee
Members

Articles (4223)

Showing 12 of 4223 View All
Showing 150 of 352 pages

Two-strike Ebola vaccine enters human trials

The vaccine, which is based on the Oxford/AstraZeneca COVID-19 vaccine, is designed to target both the Zaire and Sudan species of Ebola virus.

India’s pneumococcal vaccine rollout will save 50,000 children a year

Pneumococcal Conjugate Vaccine has now been introduced in every state in India, meaning this lifesaver will be available to every child in the country.

India completes national introduction of pneumococcal conjugate vaccine

Over 90% of children born in India every year will have access to the vaccine thanks to the efforts of the Government of India, Gavi, the Vaccine Alliance and partners, who collaborated on the nationwide introduction of PCV into the country’s…

Pakistan set to vaccinate more than 90 million children as part of global fight against measles and rubella

The campaign is one of the largest in history and will aim to reach over 95% coverage. Oral polio vaccine will also be integrated in the campaign to support polio eradication in Pakistan.

Investments in Disease Surveillance Support Kenya’s Response to COVID-19

In a conversation with Maria Deloria Knoll, PhD, IVAC’s Director of Epidemiology, Dr. Kagucia shared how Gavi-supported activities facilitated Kenya’s COVID-19 response by expanding capacity, testing, and partnerships.

Lagos steps up the fight against COVID-19

Lagod – the epicentre of COVID-19 in Nigeria – is ramping up its vaccination campaign, with committed leaders and ambitious targets.

Can vaccines unlock access to health care?

Zero-dose children who never receive a single vaccine are also more likely to miss out on crucial primary health care services.

Discoveries from vaccine implementation

In episode 8 of the Global Health Matters podcast, we spoke to Professor Margaret Gyapong of the University of Health and Allied Sciences in Ghana and Dr Lee Hampton of Gavi, the Vaccine Alliance. These experts shared their views on how…

Sickness and survival in pre-COVID-19 Nepal

A gripping documentary about a family's struggle with the emotional and financial consequences of severe pneumonia.

Nose sprays, needle-free patches, durable immunity: towards the next generation of COVID vaccines

The development of COVID vaccines has already been explosive. There are more innovations on the way.

White-tailed deer found to be huge reservoir of coronavirus infection

In a sample of white-tailed deer, 80% were found to have an active COVID infection.

Subscribe to our newsletter